Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fomitopsis cajanderi hot ethanol extract is a research-stage natural product extract derived from the fruiting body of the Fomitopsis cajanderi mushroom, also known as the Rosy Polypore [1]. Prepared via a two-hour Soxhlet extraction in ethanol using a cold finger condenser, this crude extract has been evaluated in academic research for its potential therapeutic properties [1]. In preclinical studies, the extract demonstrated concentration-dependent cytotoxicity against human MCF7 mammary adenocarcinoma and U-937 histiocytic lymphoma cancer cell lines, with more pronounced tumoricidal effects observed in the U-937 cells [1]. Currently, there is no commercial developer, and the extract remains in the early academic research stage with no identified molecular targets [1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fomitopsis cajanderi hot ethanol extract.